InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Girao Tiago, 首席财务官. Director active across 2 companies, notably Immunovant, Inc.. Aggregated, 8 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €883k. History available since 1 May 2025. The latest transaction was disclosed on 23 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Girao Tiago
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
6,798 股@ US$38.690.0032% mcap26.1% 占其流量Common StockSEC:0001618670-26-000004:0
10,000 股Common StockSEC:0001764013-26-000072:0
10,000 股Common StockSEC:0001764013-26-000072:1
25,760 股@ US$29.620.012% mcap50.0% 占其流量Common StockSEC:0001764013-26-000056:0
64,968 股0Common StockSEC:0001764013-26-000032:0
208,388 股0Common StockSEC:0001415889-25-012047:0
35,250 股Common StockSEC:0001140361-16-050458:0
35,250 股Common StockSEC:0001140361-16-049631:0
8 条申报中的 8 条
About Girao Tiago
Tiago Girao is the Chief Financial Officer of Immunovant, Inc. He is responsible for financial management and strategy, playing a key role in the company's performance.
